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ABSTRACT 
The purpose of thi s study is to investigate whether 
daily passive range of motion treatment will 
knee range of motion in the rigid patient. 
wi th moderate to severe rigidi ty due to 
prevent loss of 
Eleven subjects 
Alzheimer's or 
dementia were selected. Medical records ,,,ere reviewed and 
knee ROM measurements from 3 consecutive years were recorded 
and analyzed. Federal regulations pertaining to treatment 
are discussed. The numbers of people affected and the costs 
of caring for them are described. The urgent need for 
clinical research to identify the most appropriate treatment 
is addressed. A literature review of studies relating to 
rigidity and exercise or passive motion is included. 
Results suggest that passive range of motion is not an 
effective way to maintain motion in a rigid knee. 
vi 
CHAPTER I: INTRODUCTION 
Muscle Tone and Rigidity 
Normal 
movement. 
systems: 1 
muscle tone is a 
It is dependent on the 
prerequisite 
integrity of 
for normal 
a number of 
1) the precentral motor cortex (Brodman's areas 4,6) 
2) the basal ganglia 
3) the midbrain 
4) the vestibulum 
5) the spine 
6) the neuromuscular system. 
The basal ganglia is a system that is not yet 
completely understood. The functions of the basal ganglia 
include inhibition of muscle tone, controlling automatic 
motor acti vi ties, and maintaining background support for 
static muscle activity.2 The basal ganglia play an 
important role in the creation of abnormal muscle tone of 
the akinetic-rigid syndromes, particularly Parkinson's 
disease, Alzheimer's disease, and head injury. 
Rigidi ty is a state of abnormal muscle tone in which 
there is hypertonia of both the agonist and antagonist 
muscle groups, resulting in increased resistance to passive 
movement in any plane and at any speed of movement, which is 
-1-
-2-
relatively constant throughout the range of passive 
movement. If a tremor is also present, it may be felt as a 
rhythmic catch in the muscle under stretch. This is termed 
"cogwheel rigidity." 3-5 Rigidi ty may be severe enough to 
limit the range of movement available. 6 It is not affected 
by posture.? EMG studies may shmv continuous muscle 
activity, even in a muscle at rest. 5 ,S Often the neck and 
trunk musculature are more rigid than limbs. 3 
In attempts to move a rigid limb, there may be 
involuntary contraction in both the muscle being stretched 
and the muscle being shortened. 5 ,9 The occurrence of 
increased muscle activity in a muscle being shortened is 
known as the Westphal phenomenon or the shortening 
reaction. The shortening reaction is present in normal 
muscles, but is exaggerated in parkinsonian rigidity,9,lO 
and may last as long as the muscle is in the shortened 
position. The contraction in the muscle being stretched is 
due to increased tonic stretch reflexes and increased 
long-latency components of the stretch reflex. 5 ,9,11,12 
Rigidi ty is one of the hallmarks of Parkinson I s disease 
and is also a common feature of a group of pathologies which 
have in common a bilateral involvement of the basal ganglia, 
resulting in the Akinetic-Rigid Syndrome. (Table 1) 
The basal ganglia are a group of structures that are 
separate anatomically but connected physiologically.13 
Together they function as a control circui t which works very 
-3-
closely wi th the cerebral cortex for motor control. They 
appear to be essential for the initiation of movement and 
for control of muscle tone, as 
basal ganglia precede those 
Functionally the basal ganglia 
called the neostriatum) which 
action potentials in the 
in the motor cortex. 14 
incl ude the str ia tum (a Iso 
consists of the caudate 
nucleus and putamen, the globus pallidus, the substantia 
nigra, and the subthalamic nucleus. 14 ,15 Neurotransmitters 
found in the basal ganglia include dopamine (DA) , 
acetylcholine (ACh), glutamate, and gamma-aminobutyric acid 
(GABA) . In addi tion, a number of neuropeptides, such as 
enkephal in, substance P, and serotonin, are also found in 
the basal ganglia. (Table 2) 
There is a very · complex network of nerve pathways 
connecting II (1) the cerebral cortex 
the cerebrum, (2) the thalamus and 
and basal ganglia in 
subthalamus in the 
diencephalon, (3) the red nucleus and sUbstantia nigra in 
the mesencephalon, 
hindbrain. 1116 The 
and (4) 
basal ganglia 
the cerebellum 
do not give rise 
in the 
directly 
to descending pathways; rather, the influence is directed 
toward the cerebral cortex and the brainstem nuclei that 
give rise to the descending tracts to the neuromuscular 
system. 17 
One of these nerve pathways is a mutual inhibi tor 
pathway 
to the 
from the striatum (caudate nucleus and putamen) 
substantia nigra, where it secretes GABA at its 
-4-
termination. There is also a pathway from the substantia 
nigra back to the caudate nucleus and putamen, with the 
inhibitor dopamine secreted at the terminations of the 
axons. 14 
The pathway from the cerebral cortex to the striatum to 
the globus pallidus, to the thalamus, and back to all areas 
of the cortex is a negative feedback loop. The section of 
the pathway from the striatum to the globus pallidus is 
inhibitory 1vith the inhibitor GABA transmitted at the nerve 
endings. 
There are many other pathways as well, but "one of the 
general effects of diffuse basal ganglia excitation is to 
inhibi t muscle tone throughout the body ... whenever 
widespread destruct ion of the basal gang 1 ia occurs, this 
causes muscle rigidi ty throughout the body. ,,18 Due to the 
loss of inhibition there is increased input to the alpha and 
gamma motor neurons which may result in hypertonia. 2 In 
addition, increased tonic stretch reflexes and increased 
long-latency components of the stretch reflex are also 
thought to be involved in the creation of rigidity 15 
al though the exact pathophysiology is not yet understood. 
since long-latency 
through the basal 
stretch reflex 
ganglia, it 
path1vays 
appears 
do not pass 
that their 
magnification represents a release from inhibition. 13 
To summarize, "rigidity appears to be a consequence of 
over-acti ve long-latency and tonic stretch reflex mechanisms 
-5-
in brain and perhaps in spinal cord, released from 
control by basal ganglia damage.,,19 
Alzheimer I s di sease, w·hich is one of the group of 
pathologies included in the Akinetic-Rigid Syndromes,I3 is a 
chronic progressive disease. It is characterized by diffuse 
cortical atrophy, neurofibrillary tangles, and senile 
plaques in the cerebral cortex. 20 These plaques are also 
sometimes found in the basal ganglia. 1 Rigidity is the 
result if the basal ganglia are affected. 
Thus, the basal ganglia system is intimately involved 
in the control of muscle tone. It is 
interacts with the cerebral cortex, 
nucleus and the cerebellum. They 
a complex system that 
the thalamus, the red 
exhibit an overall 
inhibitory influence on the cerebral cortex and the 
brainstem nuclei that give rise to the descending tracts. 
Bilateral 
rigidity, 
damage to 
apparently 
the basal ganglia 
due to the loss of 
system results 
the inhibition 
in 
of 
the cerebral motor cortex. There is increased input to the 
alpha and gamma motor neurons, increased tonic stretch 
ref lexes, and 
stretch reflex. 
increased long-latency components of the 
Although the exact pathophysiology remains 
unclear, it appears that these changes are due to the loss 
of inhibition caused by damage to the basal ganglia. The 
rigidi ty found in some Alzheimer I s/dementia victims is due 
to this pathology. 
-6-
Nature and Extent of the Problem 
The number of nursing home residents with range of 
motion limitations due to rigidity is significant. 
Parkinsonian rigidity is a frequent feature in the natural 
history of Alzheimer's disease,13,21-25 with estimates of 
prevalence ranging from 9% to 92%.21-25 In normal elders, 
rigidity occurs in only 3% of the population. 23 Molsa 23 
found in separate studies that 
Alzheimer's population exhibited 
63% and 
rigidity. 
67% 
Mild 
of the 
rigidity 
was found in 26%, moderate rigidity in 37%, and severe 
rigidity in 36% of those exhibiting rigidity. Severe 
rigidity often results in loss of range of motion. 6 
In 1986 there were 2-2.5 mi 11 ion people in the Uni ted 
States with Alzheimer's, or related dementing disorders, and 
this number is expected to double or even triple over the 
next 40-50 years as the population continues to age. 26 ,27 
The 85 and older segment of the population is the fastest 
growing segment, 28 and the prevalence of Alzheimer's in this 
age group is estimated to be 20-30%.27,28 Alzheimer's and 
dementias account for up to half of the nursing home 
admissions in the United States. 29 The cause of Alzheimer's 
is unknown and there is no effective medical treatment 
available, so effective management of symptoms must be the 
focus of care. 
In recent years, adequate and appropriate care for the 
Alzheimer's patient has received increased attention, wi th 
-7-
establishment of special care units specifically designed 
to meet their physical and behavioral needs. The cost of 
caring for the Alzheimer I s patient is tremendous, wi th 
estimates ranging from $15 billion to $34 billion spent per 
year in the Uni ted States. 26,30 Of this amount, 1/3 to 1/2 
is federally funded, primarily through Medicaid. 26 Due to 
the magnitude of the population and costs involved, it is 
critical that care and treatment provided is both 
appropria te and effective. The outcome of care is the best 
indicator of the effectiveness of care. 29 
Perry and Chu,31 in discussing cost containment and 
assessment of new technologies, made observations that also 
seem pertinent to assessment of treatment approaches. They 
sta te that "The more recalcitrant but frequently occurring 
situation arises when a technology appears 
effecti ve, but 
proportion and 
for which it 
there is insufficient knowledge 
characteristics of the patient 
can be successfully applied. 
safe and 
about the 
population 
Wi thout a 
sufficient foundation, the technology is 
selectively. ,,32 
then applied on a 
routine basis rather 
observe that "some 
than 
disciplines .... have 
They 
not 
further 
focused 
sUfficient attention on the need for critical evaluation of 
the techniques they employ.,,33 Gregoric et a1 34 noted that 
"The role of physiotherapy in parlcinsonism has been 
assessed in rather few clinical studies and there is a lack 
of quantitative data and experimental evidence of the 
-8-
therapeutic effects." Perry and Chu31 also 
"f indings may prevent the entrenchment of 
observe that 
nonefficacious 
therapies." Research conducted in an effort to identify 
both effective and wasteful treatment will help to promote 
high quality care that is as cost effective as possible. 
Passive Range of Motion Exercise 
Pass i ve range of motion (PRm1) exercises have been an 
accepted form of treatment 
prevent the formation of 
for decades. 
adhesions and 
joints affected by trauma or disease. 
They are used to 
contractures at 
During healing, if 
motion of a joint is maintained, the connective tissue laid 
down has fibers running in all directions, wi th no 
discernable pattern. This is loose or areolar connective 
tissue. In scar formation, or in immobilized areas, the 
connective tissue developed is dense and fibrotic. 
Impaired circulation, trauma, edema, and immobilization all 
increase the risk of formation of dense rather than loose 
connective tissue. 35 Passive range of motion exercises 
under these conditions are of proven value; Kottke 35 states 
that a joint should be moved through its full range 3 
times, twice a day to promote formation of loose connective 
tissue. 
Over the years, PROM has become standard nursing 
procedure for patients ivho are immobile or who have joint 
limitations. Nursing texts indicate that PROM will achieve 
-9-
reduction in rigidity, increased motion at joints, lessened 
edema, and contracture prevention. 36-39 PROM has not been 
proven to have a beneficial effect in maintaining or 
increasing 
rigidity. 
providing 
j oint range of 
In spite of the 
PROM to nursing 
motion in the presence of 
lack of clinical studies, 
horne residents with joint 
limi tations is now required by federal regulations and 
guidelines. 40 ,41 
OBRA Regulations 
The Omnibus Budget Reconciliation Act of 1987 (OBRA) 
was in part directed at cost containment for health care in 
long term care facilities. Regulations were written to 
control quality of nursing care. The Health Care Financing 
Administration 
for Medicare 
(HCFA), which 
and Medicaid, 
is the federal funding agency 
wrote the guidel ines for 
interpretation of the regulations. State health department 
survey teams use these regulations and guidelines to 
determine whether long term care facili ties meet minimum 
standards of health care. Long term care providers must 
meet these "conditions of participation" in order to 
receive Medicare and Medicaid monies. 
OBRA regulation #483.25(e)40 (Appendix 1) reads: 
"Level B reguirement: Range of motion. Based on the 
comprehensive assessment of a resident, the facility must 
ensure that--(l) A resident who enters the facility without 
-10-
a limi ted range of motion does not experience reduction in 
range of motion unless the resident's clinical condition 
demonstrates that a reduction in range of motion is 
unavoidable i and (2) .A resident wi th a limited range of 
motion receives appropriate 
increase range of motion and/or 
in range of motion." 
treatment and services to 
to prevent further decrease 
HCFA's interpretive guidelines 41 for this regulation 
include the following: 
"The clinical condi tion that may demonstrate that a 
reduction in range of motion is unavoidable is: limbs or 
digits immobilized because of injury or surgical procedures 
(e.g., surgical adhesions). 
This clinical condi -cion may demonstrate that a 
reduction in range of motion is unavoidable only if 
adequa te preventive care was provided, and I imi ta tion in 
range of motion and/or muscle atrophy developed anyway." 
The guidance to surveyors41 reads in part: "Clinical 
condi tions that are the primary risk factors for a 
decreased range of motion are ... pain, 
arthritis or immobil i ty associated wi th 
Alzheimer's disease." They then ask: "For 
residents who have limi ted range of mot ion, 
spasms, and 
late 
all 
what 
stage 
sampled 
is the 
facility doing to prevent further declines in range of 
motion?--Are passive ROM exercises provided and active 
range of motion exercises supervised as per the plan of 
care? .. "(Appendix 2) 
CHAPTER II: LITERATURE REVIEW 
Parkinsonian rigidity (found in Parkinson's, 
Alzheimer's, 
understood. 
and head inj uries) is still not clearly 
Most studies have focused on the neurological 
basis of rigidity. Lee and Tatton 12 compared the EMG 
responses of normals and parkinsonian patients to sudden 
limb movements produced by load changes. They found that 
there were three distinct early peaks of EMG activity after 
limb displacement, which they labeled M1 (tendon jerk 
reflex), M2 (long-latency reflex), and M3. In parkinsonian 
rigidi ty, the EMG response was very large and of long 
duration, with an amplitude from 3 to 4 times larger than 
that found in normals. They also calculated a motor 
response index (MRI) which compared the EMG activity during 
the response to limb movement to the EMG activity at rest, 
prior to the movement. In the parkinsonian patients with 
rigidi ty, the MRI was 9 times larger than that recorded in 
normals. 
Burke et a1 5 studied reflex mechanisms in parkinsonian 
rigidi ty. They describe involuntary contractions of both 
agonist and antagonist on attempts to move a limb, with the 
result being the "splinting" of a limb. They suggest that 
this rigidity may be the result of a decrease in modulation 
of cortical motor output resulting from disturbed 
-11-
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inhibitory feedback from the basal ganglia. They found 
that the shortening reaction (involuntary contraction in a 
muscle being shortened) may continue for as long as the 
muscle is maintained in the shortened position. 
Considering such findings, they suggest that the primary 
motor defect in rigidity is the inability to relax normally 
due to disturbances in the influences from higher motor 
centers. 
The influence of passive exercise on rigidity was 
studied by Gregoric et al. 11 They used EMG and 
biomechanical recordings of responses to passive sinusoidal 
movement of the foot, which was rotated at 4 different 
frequenc ies for 15 minutes wi th constant ampl it ude. They 
found sustained periods of EMG acti vi ty wi th both passive 
shortening and passive stretching of the muscles, wi th more 
acti vi ty noted in the anterior tibialis than in the triceps 
surae. 
reduced 
Their results showed that the EMG acti vi ty Ivas 
wi th faster passive movement, suggesting that 
rigidi ty is somewhat velocity dependent, al though less so 
than spasticity. This would indicate that if PROM is being 
used in patients with 
should perhaps attempt 
parkinsonian rigidity, clinicians 
to use faster velocity movements to 
try to reduce shortening reactions and stretch reflex 
reactions during movement. 
Andrews, Burke, and Lance9 studied 34 patients with 
rigidi ty. They recorded EMG tracings produced by passive 
-13-
movements of the knee, elbow or wrist. Joints were moved 
over a range of velocities through 100 0 to 110 0 of joint 
rigidity movement. They found that patients with severe 
showed EMG responses even at the slowest possible movement 
veloci ties and that static reflexes were prominent with 
maintained stretch. Hamstrings were usually more severely 
affected than quadriceps, and biceps more affected than 
tric~ps. In the more severely affected patients they 
observed that the dynamic stretch reflex occurred before 
the muscle was fully stretched. The static stretch ref lex 
was recorded in the hamstrings of 17 of 19 patients. This 
was more conspicuous in those with more severe disability, 
which is consistent wi th increasing fusimotor bias due to 
lack of inhi bi tion from higher centers. The pertinent 
finding is that passive 
activity. 
movement produces increased EMG 
There are other studies in the literature which 
address the responses of muscles to movement 
patient. 10 ,42,43 There are almost none which 
in the rigid 
look at the 
effects of an exercise program on rigid patients. Palmer 
et al 44 did a comparison of two different types of exercise 
programs on parkinsonism. One group followed a stretching 
program and the other followed an upper body karate 
training 
matching 
program. 
stage of 
Fourteen patients were paired by 
disease, sex, and age, with one of each 
pair assigned to the stretching group and one to the karate 
-14-
group. Each group met for 1 hour, 3 times per week. A.t 
the end of the program nei ther group showed any change in 
resting rigidity or in acti va ted rigid i ty (measured in one 
arm while the other arm performed a pursuit test). 
There were no studies found in the literature which 
investigated the effectiveness of a PROM program for 
maintaining joint range of motion in the rigid patient. 
CHAPTER III: METHOD 
Subjects 
This study was approved by the Human Subj ects Review 
Board at the University of North Dakota at Grand 
Forks. (Appendix 3) The purpose of the study is to 
investiga te the effectiveness of PROM exercise in 
preserving knee ROM in the rigid patient. 
Subjects chosen for this study were all residents of a 
skilled nursing facility. All residents who met all of the 
stated criteria were included in the study. Criteria for 
inclusion were: 
1) diagnosis of Alzheimer's or dementia 
2) moderate to severe rigidity as defined by the 
Van Dillen-Roach scale of rigidity 6 
3) loss of range of motion at the knee at the time 
of the study 
4) received passive range of motion to the 
knees daily over the period of the study 
5) goniometric measurements were available from 
physical therapy evaluations conducted in 
1990, 1991, and 1992. 
Eleven residents, 8 women and 3 men, aged 63 to 99 
years (X=87) met the criteria. 
-15-
One male subject had 
-16-
goniometric measurements available for only one knee, which 
gave a total of 21 knees involved in the study. 
None of the subj ects had a secondary diagnosis of 
Parkinson's disease. Fi ve of the subj ects had a secondary 
diagnosis of osteoarthri tis. None had rheumatoid 
arthritis. Length of time since identified onset of 
illness ranged from 1 to 11 years, wi th a mean of 6 years. 
Eight of the subj ects were unable to ambulate even with 
maximal ass ist, 
(approximately 
collected. 
Procedure 
Permission 
administration 
3 
20' ) 
were able to ambulate short distances 
with assist of two at the time data was 
was obtained from nursing home 
to review the charts of those residents 
identified as appropriate subjects. Data collected from 
the medical records included diagnosis of Alzheimer's, 
dementia, Parkinson's, or arthritis, and age, sex, length 
of time since identified onset of Alzheimer's disease or 
dementia, and knee ROM measurements from phys ical therapy 
evaluations from three consecutive years (1990, 1991, and 
1992). (Appendix 4, Table 3) 
Data Analysis 
Data analysis was performed on a personal computer 
us ing a sta ti stical analys is software package. (Sta ti stix) 
Descriptive sta ti st ics (mean, standard deviation, minimum, 
maximum) were calculated for age, time since onset of 
-17-
illness, change in ROM from year 1 to year 2, change in ROM 
from year 2 to year 3, and total change in ROM from year I 
to year 3. In addition, the study group was subdivided 
into a group with secondary diagnosis of arthritis and a 
group without arthritis to 
seen could be a ttri buted 
determine 
to the 
whether any changes 
presence of that 
condi tion. The study group was also subdivided into a male 
and a female group to test gender di fferences. The group 
was subdivided into those with time since identified onset 
of illness of greater than 6 years, and those with time 
since onset of 6 years or less. 
The Wilk-Shapiro Rankit Plot test was used to 
determine whether each variable conformed to a normal 
distribution. The results of these tests were then used to 
select the appropriate test for data analysis. 
The Wilcoxon signed-rank test was used to compare ROM 
measurements from year I to year 2 and year 3. The 
two-sample t test was used to compare the arthri tis to the 
nonarthri ti s group, the male to the female group, and the 
long onset to the short onset group. 
CHAPTER IV: RESULTS 
Changes in Knee ROM Over a 2 Year Period (Tables 4,5) 
The mean age of all subj ects (n=21) was 87.2 years, 
wi th a range of 63 to 99 years. The mean change in knee 
ROM from 1990 to 1991 was -6.000, with a standard deviation 
of 13.78°. The largest loss observed vlas -400, and the 
largest gain was 23°. 
The mean change from 1991 to 1992 was -15.660, with a 
standard deviation of 18.200. The largest loss was -60°, 
and the largest gain was 20°. 
period was The mean total loss over the two year 
-21.660, with a standard deviation of 20.69°. The greatest 
loss for a single subject over the two years was -710, and 
one subject had a total gain of 23°. 
The Wilcoxon signed-rank test found the loss of 21.66° 
from 1990 to 1992 to be significant (p< 0.001). 
Differences Between Arthritis and Nonarthritis Groups 
There were 10 subj ects wi th a diagnosis of arthri tis, 
wi th a mean age of 90.0 years. The mean change the first 
year was -6.40 for the arthritis group, with a standard 
deviation of 16.240 and a range of -400 to +23°. The mean 
change the second year was -11.80, with a standard 
deviation of 16.730 and a range of -330 to +20°. 
-18-
The mean 
-19-
total change over the two years for this group was -18.2 0 , 
with a standaid deviation of 17.780 and a range of -330 to 
+23°. 
The nonarthri tis subgroup consisted of 11 subj ects, 
whose mean age was 84.6 years. The mean change the first 
year for this group was -5.64°, wi th a standard deviation 
of 11.93° and a range of -31 ° to + 1 00. The second year the 
standard deviation of mean change was -19.18 0 , with a 
19.550 and a range of -600 to -20. The mean total change 
over the two years was -24.82°, with a standard deviation 
of 23.430 and a range of -710 to +70. 
The two-sample t test found no significant difference 
between the arthritis and nonarthritis groups (t=.72, 
df=19, p=O. 478) when comparing total losses over the 2 
years. 
Differences Between Male and Female Groups 
There were 5 male subj ects, whose mean age was 91.8 
years. The mean change the first year for male subj ects 
was -3.20, with a standard deviation of 4.60 and a range 
from -100 to 00. The mean change the second year was 
-19.60°, 1vi th a standard deviation of 15.09° and a range of 
-330 to -20. The mean total change over the 2 year 
period for males was -22.8°, wi th a standard deviation of 
11.0990 and a range of -330 to -80. 
There were 16 females in the study, with 
85.75 years. The mean ROM loss over the 
a mean age of 
first year was 
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-6.87°, with a standard deviation of 15.630 and a range of 
-40° to +23°. The mean change the second year was -14.440, 
with a standard deviation of 19.340and a range of -600 to 
+20°. The mean total change was -21.30 with a standard 
deviation of 23.1850 and a range of -710 to +230. 
The two-sample t test found no significant difference 
between the males and females over the two years (t=.14, 
df=19, p=0.893). 
Differences Between Short Time Since Onset and Long Time 
Since Onset Groups 
There were 10 subj ects whose time since identified 
onset of illness was 6 years or less, whose mean age was 
87.4 years. The mean loss over the first year was -4.900, 
with a standard deviation of 12.360 and a range of -310 to 
+10°. The mean change the second year was -19.200, with a 
standard deviation of 13.190 and a range of -400 to 00. 
The mean total change over the two years was -24.100, with 
a standard deviation of 20.740 and a range of -71 to +70. 
There were 9 subj ects, mean age of 87.6 years, whose 
time since onset of illness was greater than 6 years. The 
mean change over the first year for this group was -2.440, 
with a standard deviation of 11.520 and a range of -150 to 
+23°. The mean second year change was -15.770, with a 
standard deviation of 21.400 and a range of -600 to 0°. 
The mean total change was -18.22°, with a standard 
deviation of 23.600 and a range of -600 to +230. 
-21-
The two-sample t test showed no significant difference 
between the short and long onset groups (t=. 58, df= 17, 
p=O.571). 
To summarize, there were highly significant losses of 
knee range of motion over the period of the study. There 
were no s igni f icant di fferences between subj ects with and 
wi thout arthritis, between males and females, or between 
those with 6 or less years since onset of illness and those 
with more than 6 years since onset of illness. 
CHAPTER V: DISCUSSION 
The results of this study suggest that passive range 
of motion is not an effective way to prevent loss of range 
of motion in the rigid patient. However, this study, as 
designed, has a number of limitations that require the 
results to be interpreted with caution. Due to the lack of 
a control group, it is impossible to determine whether PROM 
treatment is more effective than no treatment. During the 
planning of this 
get permission 
independent study, 
from the ND State 
an effort was made to 
Health Department45 to 
incl ude a control group which would receive no treatment 
and which would be moni tored closely, with PROM to be 
ini tiated if losses of ROM greater than those observed in 
the study group occurred. Permission was denied, as this 
would be 
Personnel 
references 
considered withholding necessary 
at the NDSHD were unable to ci te 
which support the suggest ion 
any 
that 
treatment. 
studies or 
PROM will 
prevent losses of ROM in a rigid patient. In 
that, the North Dakota Health Department is bound 
spi te of 
to abide 
by the regulations and interpretive guidelines created by 
OBRA40 and the Health Care Financing Administration41 • 
Correspondence with HCFA46, Senator Kent Conrad47 , 
Representative Byron Dorgan48 , and Carole Lewis, PhD, PT49, 
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the editor of Topics 
resulted in no cited 
for the rigid patient. 
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in Geriatric Rehabilitation, also 
sources of support for PROM treatment 
It is difficult to understand how federal regulations 
could be promulgated without clinical research support, but 
this is the case relevant to the passive ROM 
regulation/guidelines. This demonstrates not only the 
urgent need for further research in physical therapy, but 
also the need to evaluate the process by which regulations 
are created. It 'i{ould seem logical that, at a minimum, a 
regulation such as 483.25(e) would require proven 
effectiveness of the required treatment. Without that 
basis, it is perhaps irresponsible to require a specific 
unproven treatment. This 
significant time commitment 
approach not only requires a 
on the part of caregivers to 
provide the treatment, but it also creates the impression 
in a large medical community that this treatment has been 
respons ibly evaluated and found effective, thus possibly 
closing the door to an ongoing search for the best 
available treatment for the target patient population. 
This study has other limitations as well. In this 
nursing care facility, there has been inconsistency in the 
manner of documenting PROM treatment. Thus it cannot be 
assumed that each resident received PROM each day during 
the study, even though that is the recommendation from 
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physical therapy and this approach is incl uded on the 
interdisciplinary care plan. 
Another I imi tation is the variety of caregivers 
performing the treatment dur ing the per iod of the study. 
The caregivers involved in this study included certified 
nursing assistants, a certified occupational therapy 
assistant, and physical therapy aides. Training in 
performing PROM cannot be assumed to be equivalent among 
these caregivers. 
A prospective 
could eliminate many 
study designed wi th 
of these problems. 
a control group 
Ideally, further 
studies in this area will include larger numbers of 
subjects in more than one nursing care facility, with a 
control group matched for age, sex, and degree of rigidi ty 
present. Those caregivers who provide the PROM would be 
trained with the same protocol, and documentation of the 
trea tment frequency would be reI iable and cons i stent. The 
results of such a study could be interpreted more 
confidently than the results of this study. 
This study does indicate that further studies need to 
be done regarding the effectiveness of PROM, and that the 
process of creating regulations and guidelines relating to 
heal th care need to be monitored more closely by medical 
professionals in order to prevent further instances of 
mandating unproven treatments. 
TABLES 
-25-
TABLE 1: CAUSES OF THE AKINETIC-RIGID SYNDROME13 
ADULTS 
Pure Parkinsonism: 
Parkinson's disease 
Post-encephalitic parkinsonism 
Drug-induced parkinsonism 
Parkinsonism-plus: 
Progressive supranuclear palsy 
Multiple system atrophy-
Olivo-ponto cerebellar atrophy 
Strionigral degeneration 
Shy-Drager syndrome 
Basal ganglia calcification 
Parkinsonism in dementia: 
Alzheimer's disease 
Cerebrovascular disease-
Multi-infarct 
Binswanger 
Head injury 
Anoxia 
Hydrocephalus 
JUVENILES 
Wilson's disease 
Hallervorden-Spatz disease 
Pallidal degenerations 
Juvenile Huntington's disease 
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TABLE 2: NEUROTRANSMITTERS IN THE BASAL GANGLIA 
NEURO- AXONS AXONS 
TRANSMITTER FUNCTION ORIGINATE IN TERMINATE IN 
GABA inhibitory caudate nucleus substantia nigra 
putamen 
dopamine inhibitory substantia nigra caudate nucleus 
putamen 
ACh excitatory cerebral cortex caudate nucleus 
thalamus putamen 
serotonin inhibitory brain stem caudate nucleus 
(raphe nuclei) putamen 
substance P excitatory caudate nucleus substantia nigra 
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TABLE 3: COMPREHENSIVE DATA 
YEARS TOTAL KNEE ROM (0) 
SUBJECT AGE SEX ONSET ARTHRITIS 1990 1991 1992 
1. L 63 F 7 no 110 110 70 
R 63 F 7 no 110 110 50 
2 . L 85 F M* yes 60 45 30 
R 85 F M yes 60 20 40 
3. L 93 F 11 no 60 45 40 
R 93 F 11 no 60 45 40 
4. L 82 F 3 no 50 60 57 
R 82 F 3 no 40 50 34 
5. L 91 F 3 yes 40 42 20 
R 91 F 3 yes 45 30 30 
6. L 84 F 1 yes 70 60 45 
R 84 F 1 yes 70 60 40 
7. L 99 F 8 yes 94 95 95 
R 99 F 8 yes 62 85 85 
8. L 94 M 8 no 70 60 55 
R 94 M 8 no 58 52 50 
9. L 89 M 9 no 120 120 95 
R 89 M 9 no M* M M 
10. L 89 F 6 no 121 90 50 
R 89 F 6 no 55 50 40 
11. L 91 M 4 yes 120 120 87 
R 91 M 4 yes 120 120 87 
* denotes missing data 
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TABLE 4: MEAN AGE, CHANGE AND ONSET BY GROUPS 
MEAN MEAN CH.ANGE MEAN TIME 
AGE YEAR1-YEAR3 SINCE ON-
n (YRS) (DEGREES) SET (YRS) 
All subjects 21 87.2 -21.67 6.0 
Females 16 85.75 -21. 3 5.6 
Males 5 91.8 -22.8 6.6 
Arthritis 10 90.0 -18.2 3.2 
Nonarthritis 11 84.6 -24.8 7.2 
Onset 6 years 9 87.6 -18.22 8.6 
Onset 6 years 10 87.4 -24.1 3.4 
or less 
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TABLE 5: CHANGES IN KNEE ROM BY GROUP 
(changes expressed in degrees) 
----RANGE----
SUBJECTS N MEAN SD MIN MAX 
All subjects 21 
Change year 1 - 6.00 13.78 -40 +23 
Change year 2 -15.66 18.20 -60 +20 
Total change -21.66 20.69 -71 +23 
Arthritis group 10 
Change year 1 - 6.4 16.24 -40 +23 
Change year 2 -ll.8 16.73 -33 +20 
Total change -18.2 17.78 -33 +23 
Nonarthritis group 11 
Change year 1 - 5.64 11.93 -31 +10 
Change year 2 -19.18 19.55 -60 - 2 
Total change -24.82 23.43 -71 + 7 
Male group 5 
Change year 1 - 3.2 4.60 -10 0 
Change year 2 -19.60 15.09 -33 - 2 
Total change -22.8 11.10 -33 - 8 
Female group 16 
Change year 1 - 6.87 15.63 -40 +23 
Change year 2 -14.44 19.34 -60 +20 
Total change -21.3 23.19 -71 +23 
Short onset group 10 
Change year 1 - 4.90 12.36 -31 +10 
Change year 2 -19.20 13.19 -40 0 
Total change -24.10 20.74 -71 + 7 
Long onset group 9 
Change year 1 - 2.44 11.52 -15 +23 
Change year 2 -15.77 21.40 -60 0 
Total change -18.22 23.60 -60 +23 
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APPENDIX 1: OBRA REGULATION #483.25(e) 
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Federal Register I Vol. M. No. Z1 I Thursday, February 2, .1989 I Rules and Regulationl 5385 
(i) Developed within 7 day. after 
completion of the comprehensivD 
assessment: 
(ii) Prepared by an interdisciplinary 
team. that effective October 1.1990. 
includes the attending physician. a 
registered nurse with responaibility for 
the resident. and other appropriate staff 
in diSciplines os determined by the 
resident's needs. and with the 
participation of the resident. the 
resident'. family or legal representative, 
to the extent practicable: and 
(iii) Periodically reviewed and revised 
by a team oC qualified persona after 
each assessmenL 
(3) The services provided or arrdnged 
by the facility must-
(i) Meet professional standards of 
quality; and 
(ii) Be provided by qualified penons 
in accordance with each resident's 
written plan oC care. 
(e) Level B requirement: Discharge 
summary. When the facility anticipates 
discharge, a resident must bave a 
discharge summary that include_ 
(1) A recapitulation oC the resident's 
stay: 
(2) A final summary of the resident's 
status to Include items in paragraph 
(b)(2) oCthis secllon. at the time of the 
discharge that is available Cor release to 
authorized, persons and agencies. with 
the consent of the resident or legal 
representative: and 
(3) A post-discharge plan oC care that 
developed with the participation of the 
resident and his or her family, which 
will assist the resident to adju.t to his or 
her new living em'ironmenL 
(f) Level B requirement: Preadmission 
$cror.ning for melltally ill individualll 
and individuals .... ith mental retardation. 
(1) A nursing facility must not admit. on 
or aiter January 1, 19R9, any new 
resident with-
(i) Mental iIlncss as defined In 
parngraph (f)(2)(i) of t/tis section. uoless 
the State mental health authority has 
determined, based on on independent 
physical and mental evaluation 
performed by a person or entity other 
than the State mental health authority, 
prior to admission, whether-
(A) Because of the physical and 
mental condition of the individual, the 
individual requires the level of seT\'ices 
provided by a nursing facility: and 
(H) If the individual requires such 
level of services, the individual requires 
active treatment for mental illness: or 
(ii) Mental retardation, as defined in 
paragraph (f)(2)(ii) of this section. unless 
the State mental retardation or 
developmental disability authority has 
determined prior to admission 
whether-
(A) Because of the physical and 
mental condition of the individuaL the 
Individual requires,the level of sanicas 
provided by. nuraill8 facility; and 
(B) Il the individual requireuw:h 
level of serviceJ. the individual requirel 
ectlve treatment Cor menial retardalion. 
(2) Definition. For PUI'pORl oC thil 
section-
(1) An indlvidualla cOnsidered 10 have 
"mental Hlne .... 11 the individual hu.. 
primary or IeCDDdary diagnOlil of 
mcntal disorder (al defined in tha 
Diagnostic and Statlltfcal MaDual of 
Mental Disoniel'l. 3M edition) and does 
not have a primary dlqnolil of 
dementia (incJuding Alzheimer'. diae .. e 
or a related disorder), 
(Ii) An individual i. considered to be 
"mentally retarded" 11 the individual 11 
mentally retarded or a penOD with a 
related condlUon al described in 4Z.CPR 
435.1009. 
,483.25 LII'II A ~ au.Mtr of 
-- ' 
Each retldeDt must receive the 
nccellSllry DW'Iiq. medical end 
psychosocialler'viCOlto altain and 
maintain the highest possible mental 
end phYlicallunctiOllalltalua. as 
defined by the comprehenlive 
aasellment aDd plan of care. Each 
resident must receive and the (acillty 
must provide the D8Cel1IIIry care and 
services to atlain or maintain the highelt 
prncticabJe phylicaL mentaL and 
psychosocial well·being. in accordaDce 
with the comprehensive aueumeDt and 
plan of care. 
(al Level B requirement: Activitie. 01 
daily living, Based on the 
comprehensive auelsmeDt of a resident. 
the fDcility mUlt ensure that-
(1) A resident's abilitiel in activities 
of daily Jiving do not diminilh unles, 
circumstances of the individual', clinical 
condition demolUltrate that diminution 
was unavoidable. Thil incJudel the 
resident', ability to-
(i) Bathe. dreaa and groom: 
(ii) Tran.fer and ambulate; 
(iii) Toilet: 
(ivl Eat; and 
(v) To use speech.ianguage or other 
functional communication Iysteml. 
(2) A resideDtis given thl! appropriate 
treatment and servicel to maintain or 
improve hil or her abilitiel ,pecified in 
paragraph (a)(I) of thll lection; and 
(3) A resident who fa unable to carry 
out activities of daily living receivel the 
necessary services to maintain good 
nutrition. grooming. and personal and 
orDI hygiene. 
(b) Level B requirel1lent: Vision and 
hearing. To ensure that residents receive 
proper treatment aDd allislive devices 
to mHintain vision and hearins abililies. 
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the facility must. if neceuary. aaalit the 
resident-
(1) In making appolntmentt:aad 
(Z) By ananglng Cor transportation to 
and from the office of. medical 
practitioner lpecializ.ing in the treatment 
of vision or hearing impairment or the 
omce of a profellional specialWll8 in 
the provision oC vision or hcaring 
aaaillive devlcel. . 
(c) Level B requiremt!DL' Ptesslire 
.oros. Based on the comprehensive 
&lsessment oC a resideDt. the facility 
must elUlure that-
(1) A resident who enten the facility 
without prellure eore. doel not develop 
preslure lorel unleu the individual". 
clinical condition demonstratell that 
they were unavoidable: and 
(2) A resident hilvm, pEeAure IIOreI 
receiVSl DeceuH)' treatment aDd 
servicel to promote healing. provent 
infectioD and prevent new IOres from 
developing. 
(d) uveJ B requirement: Urinary 
Incontinence. Based on the resident'. 
comprehensive assessment. the facility 
must ensure that-
(1) A resident who i. Incontinent oC 
bladder receivel the eppropriate 
treatment and IBrvi(;el to rettore 81 
much normal bladder functioning 81 
pollible: 
(2) A re.ident who eDten the CaciUty 
without an indwelling catheter i. not 
catheterized unless the resident's 
cUnical condition demonstratel that 
catheterization was neceSlary; and 
(3) A resident who is incontinent of 
bladder receives appropriate treatment 
and services to prevcnI urinary tract 
infp.&:tiona and to restore all much 
normal bladder {unction al possible, 
(e) Level B requirement: Range of 
motion. Based on the comprehensive 
asseument of a resident. the facility 
must ensure that-
(1) A resident who enters the facility 
without a limited range of motion does 
not experience reduction in ralijje of 
molion unless the resident's clinical 
condition demonstrates that a reduction 
in range of motion i. unavoidable: and 
(2) A resident with a limited range of 
motion and/or receives appropriate 
treatment and scrvices to increase range 
of motion to prevent further decrease in 
range of motion. 
(f) Level B requirement: Psychosocial 
functioning. Bued on the 
comprehensive aSleument of a reaidenL 
the facility must ensure that-
(1) A resident who displaye 
psYC;hosocial adjustment difficulty, 
receives appropriate treatment and 
services to achieve as much 
remotivation end reorientation n 
possible: and 
APPENDIX 2: HCFA INTERPRETIVE GUIDELINES 
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INTERPRETIVE GUIDELINES - SKILLED NURSING FACILITIES AND INTERMEDIATE CARE FACILITIES 
REGULATION 
(3) A resident who Is Incontinent 
of bladder receives appropriate 
treatment and services to prevent 
urinary tract Infections and to 
restore as much normal bladder 
function as possible. 
(e) Level B requirement: Range of 
!!l2li.2!! • 
Based on the comprehensive 
assessment of a resident, the 
facility must ensure that--
(1) A resident who enters the 
facility without a limited range 
GUIDANCE TO SURVEYORS 
+ If continent at admission, was the resident Identified al having risk factors of 
Incontinence (e.g., frequency of urination, with limited mobility)? 
+ What care did the resident receive to promote maintenance of continence? 
+ Old the facility attempt to manage the Incontinence without the use of an 
Indwelling catheter (e.g., a bladder training program, prompted voiding schedule, 
external catheter)? 
Interpretive Guideline; 483.25(d)(3) 
For the purposes of this regulation, urinary tract Infection (UTI) Is defined as 
colonization (growth of bacteria) of the urinary tract with signs and/or symptoms of 
UTI. Asymptomatic colonization Is not a UTI. 
Survey Procedures and Probes: 483.25(d)(3) 
For 8~led residents who are Incontinent: 
+ Is the resident adequately hydrated? 
+ How many residents currently have a UTI? 
+ Are risk factors for UTI monitored and managed (e.g., poor fluid Intake, previous 
UTII)? 
+ Are Infection control procedures In place (e.g., fluids readily available to all 
resldentl)? 
If the relldent hal an Indwelling catheter: 
+ Are tubing and/or bag properly positioned? 
+ II the staff following the facility'S protocol and/or written procedures for 
catheterization? 
+ Do all personnel wash their hands before and after 'carlng for the 
catheter/tubing/collecting bag? 
Interpretive Guideline: 483.25(e) 
Range of motion (ROM) means the extent of movement of a joint. 
The clinical condition that may demonstrate that a reduction In range of motion is 
unavoidable Is: limbs or digits immobilized because of Injury or surgical proc~res 
(e.g., surgical adheslor>.;). ' 
This clinical condition m!Y demonstrate that a reduction In range of motion is 
unavoidable only if adequate preventive care was provided, and limitation in range of 
motion and/or muscle atrophy developed anyway. 
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INTERPRETIVE GUIDELINES " SKILLED NURSING FACILITIES AND INTERMEDIATE CARE FACILITIES 
RElit.UlIOM 
of IIIOtlon does not experience 
redJction In range of IIIOtlon 
unless the resident's clinical 
condition demonstrates that a 
redJctlon In ranga of IIIOtlon Is 
unavoidable: and 
(2) A resident with a llalted 
range of mtlon receives 
appropriate treatment and services 
to Increase range of IIIOtlon and/or 
to prevent further decrease In 
rang. of IIIOtlon. 
(f) level B requirement: 
Psychosocial functioning. 
GUIDANCE TO SURVEYORS 
Consistent with the resident's comprehensive assessment and care plan, adequate 
preventive care .ay 'Include active ROM performed by the resident; pesslve ROM 
performed by staff: actlve"asslstlve ROM exercise performed by the resident and staff; 
and application of splints and braces, If necessary. 
Clinical conditions that are the prImary risk factors for a decreased range of motion 
are: 
+ Immobilization (e.g., bedfast) 
+ Deformities arising out of neurological deficits (e.g., strokes, ~ltlple 
Iclerolls, cerebral pelsy, and polio). . 
+ Pain, Ipaams, and Immobility aSloclated with arthritis or late Itage Alzheimer's 
dllease. 
Survey Procedure and Probes: 483.25(e) 
For each lampled relldent who needs routine preventive care: 
+ Observe staff providing routine ROM exerclsea. Are they done correctly? 
II there evidence that there has been a decline In sampled relldents range of IIIOtlon 
and/or muscle atrophy that was avoidable? 
+ What risk factors for a decline In range of motion were Identified? 
+ What care did the facility provide, Including routine preventive measures that 
addressed the resident's unique rllk factors (e.g., use muscle strengthening 
exercises In residents with muscle atrophy)? 
+ Was this care provided consistently? 
For all sampled residents who hive limited rlnge of motion, what Is the facility doing 
to prevent further declines In range of motion? 
+ Are passive ROM exercises provided and active range of motion exercises supervised 
as per the plan of care? 
+ Have care plan objectives and resident progress been evaluated? 
+ Is there evidence that ~are planning la changed aa the realdent's condition 
changes? 
Interpretive Guideline: 483.25(f) 
Psychosocial adjustment difficulty applies to problems residents have In adjusting to 
their life's circumstances, particularly In accommodating to living In a nursing 
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March 30, 1992 
UJrIVDSlft or HOaft DaJta.rA' S 
DlftI:tr.rXOJIU. JlBVZBW BQJUU) 
__ ~Ha~r~g~a~r~e~e~I~n~g~o~ld~ _____________ DBP~/COLLEGB Physical Therapy 
PROJECT ~I~s Passive Range of Moeion for Preveneing Loss of Knee Range of 
Hoeion in the Rigid Paeiene 
The above referenced project wa. reviewed by a designated member for the' University's 
Institutional Review Board on March 31. 1992 and the following action was taken: 
o 
o 
Project approved. DPBDIDD JlBVDnf NO. _____ • Next scheduled review is on __________________________ __ 
Project approved. ~ CADOOR!' NO. ~. 
unlese so stated in R!HARKS SECTION. 
Project approval deterred. 
(See REMARKS SECTION ,for further information.) 
No periodic review scheduled 
o Project deaJ.ecl. 
(See REMARKS SECTION for further information.) 
REMARKSs Any changes in protocol or adverse occurrences in the course of the 
research project must be reported iDDediately to the IRB Chairman or ORPD. 
, / 
I~ _. __ •• ',1 A h ll-L ttl.-~ 91 ~a.f fv )u.,uuuJ 
VIt.1;U- . ~ /YLJU..L"".1 " ~ a::r ,0 f)" : :. ~~ ~' IJ ~ d~ ~ a.~~-h ~.........--' , ' ~ 
''""2)0 ;rvcJt-~ 0-~r ~ ~~ ~ tL. G~ 
(1u..oL::t. add a.. ~U/ ~Cl.1A- /'vLa.JL ,.<Uc-~ 
\~~~~J )JYiu ~ ~ -I-v k I'~ ~ ~v. 
(}..cJa w.J.J t.-t ~rJ ~ a.~ tu-~iGtL ~"* '/ 
Please send a copy of the leteer of approval and revised "risk section" co ORPD, 
Box 8138, University Staeion. Grand Forks. NO 58202. 
cc: H. Wessman. Adviser 
Dean, Graduate School son or deSignated IRB Member Date 
view Board 
If the proposed project (clinical medical) is to be part of a research activity funded 
by ·a Federal Agency, a special assurance statement or a completed 596 Form may be 
required. Contact ORPD to obtain the required documents. (9/87) 
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EIPSIITED IlEYIEV IISIJESTED lIIIO ITBI ~mn til _lIIIIIIlAnms 
-XEIBI'T IlEYIBlIIBILESTED lIIIO ITBI -g-= ca-amn til _ IIESl.I1ATlms 
IllIVEISIlT til ..n aamrA 
.... !iI&EI'S IlEVIBI .... 
... lEY PIIOJEJS .. P'P'BIIIAL IIEVISJCIII TO AI'I'IIOVBI 
I'IIIUEtTS I8aLYlIil IIIIAII 5I&IEI:TS 
PlIICIPAl 
lIVEST I IOATCJI: Margaret Ingold PT TEUPIIIE: 722-3299 DATE: 3-7-92 
ADDI!ESS TO .. ICB IKITICE til AI'PIIJIIAL S8IU.D IE 5D1': RR 3 Box 190 Minot, ND 58701 
SCIXLIID.1EGE: Medi c1 ne IlEPMTJIBIT: Phys. Therapy I'IIII'OSID I'IIQJS:J' DATES: Sept-Dec 1992 
PIOJEtT TIM: Passive Range of Motion for Preventing Loss of Knee Range of 
Motion in the Rigid Patient 
RamI~~IB(JF~J~): ______________________________________________________________________________________ ___ 
TTPE til PIOJECT: 
...Z-. IIEV PROJECT __ CCllTlIlUATlON __ IlEJlEVAL 
__ ClWlGE IN PROCEDURE FCJI A PlEVIDUSLT APPROVED PIO.I£CT 
DISSERTATION CJI 
THESIS RESEARCH 
DISSERTATlCII(TIIESIS ADVISER. CJI SIUIEIIT MYlss: Henry C Wessman ,m PT 
PIIIJI05BI PIIOJEC1': __ IIMlLVES NEV DIUGS (1111) 
_ IIM1VES _·APPROVED US£ OF·DRUG 
X STUlEJIT RESEARCH PROJECT 
IIIVOlVES A IXXlPEIIA TI NG 
IISTITUTION 
IF NIT til nur SI&I£I:TS FALL I. NIT til TE RlUJIIIIII CLASSJFJeATlCIII. PlEASI! I_JeATE TE QASSlfleATlCII(S): 
NIIICJIS «18 YEARS) 
PI I SONERS 
PlEGIWIT \QIEJI 
AlCJlTUS£S 
...x. IlEllTAU T DI SAILED FETUSES (dementia) 
IlEMTAlLY RETARDED 
_ !lID SlLIIEJlTS (>18 TEARS) 
If YaIr PllDJECT IIM1VES NIT IUIoUI TJSSIE. IIIDT FWIDS. PAlIIIUIGIQL Sf£LlJEllS. DlllATED ClRGAIIS. fETAL MTERJAL ... PLACalTAL 
MTBIALS. CIIBX JIBE __ 
1. MSTIACT: (LINIT TD 200 IOIDS CJI LESS AlII IIICUIlE JUSTIFlCATlCII CJI IlECESSIT'( Flit USIIIG HIIIAII SUBJECTS.) 
The purpose of this study is' to Investigate the effectiveness of passive 
range-of-motion exercise in preserving flexibility of the knee joint in 
patients who exhibit rigidity due to the disease process of Alzheimer's 
disease or dementia. This is a treatment that nursing homes are required 
to provide for any resident who has joint limitations (OBRA regulation 
483.25(e), with interpretive guidelines from Health Care Financing 
Administration). Twelve to 15 subjects will be selected who meet the 
following criteria: 1) diagnosis of Alzheimer's or dementia, 2) moderate 
to severe rigidity as defined by a re~iable rigidity scale, and 3) received 
PROM to the knees at least 5-7 times per week over the time period studied. 
Potential SUbjects are residents of a skilled nursing facility and receive 
PROM as a standard part of their daily care, as required by regulation. 
Clinical records will be reviewed to obtain goniometric knee ROM measure-
ments (standard method of measuring joint range of motion) from the 
annual physical therapy assessments performed over the past 3 years. 
Data will be analyzed to determine whether loss of range of motion occurs 
in spite of regular treatment with passive range of motion exercise. 
There are no comparable studies in the literature, and this type of study 
cannot be done without human subjects. 
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PlEASE IGI'E: Only Info,...tfan pertfrwtt to yair ~t to utilize ...., sublKeS In yair Il"'Oj~ or Ktfvlty should be 
Included an till. forw. .....,.. appropriau atUdl aKtf_ fra. Y'DUI" prapoul (If AKlnv outllde fuldlnv). 
2. PIOTOCDL: (Describe Ilf"OCIIGJres to which In-. will be subjectld. 11M additional peen If nee_ry.) 
Potential subjects will be identified among the residents of Trinity 
Nursing Home. The study will be explained to those who meet the· 
criteria (and/or their legal guardians) and signed consent forms will 
obtained from those who chose to participate (or their legal guardians). 
The medical records of the selected subjects will be reviewed. Age, . 
sex, and time since diagnosis (if available) will be recorded. 
Knee range of motion measurements will be obtained for the past three 
years, from the annual physical therapy evaluations in the medical 
record. Changes in knee ROM measurements from year 1 to year 2, 
year 2 to year 3, and total change from year 1 to year 3 will be cal-
CUlated. Significant losses of ROM will be arbitrarily defined as 
greater than or equal to 7 degrees of ROM lost per year. Data will 
then be analyzed to determine if significant losses in knee ROM are 
occuring in spite of regular treatment with passive range of motion. 
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3. IElEfITS: (DHcrfbe til. t.wfft. to tile Indlvlclal or socl.ey.) 
In spite of the fact that passive range of motion is a treatment that is 
required by regulation to be provided to patients with joint limitations, 
there are no studies in the literature to support or refute the premise 
that PROM is appropriate treatmen~ for joint limitations in patients 
exhibiting rigidity. This study wOUld begin to address the question 
of the adequacy and appropriateness of the treatment required by 
regulation. This and further studies could then lead to higher quality 
of care by helping to identify treatment approaches that are effective 
and appropriate. 
4. IISIS: (DHcrlbe til. rllta to .tII. Ableet Md prec8Ut1_ tllet will be taken to .Inl.in til.. Th. concept of risk 
goes beyand phyalCIII rlak Md Inch ... rim to tile Abject's dignity ..; s.lf·~t, .. well IS ~o· 
logiCIIl, _tf_l or behavioral rlak. If cata are colitICted MIlch could prove lIamut or __ rrusing to tile 
Abjeet If anociated wltll iii. or her, tMn dlacrlbe til • ..at_ to be used to insure til. cantldlnt/.llty of 
cata obtained, Including pl_ for fl,.1 dfspoaftfcn or 'dlstructfcn, dstIri.ffng proc:earea, etc.) 
There are no physical risks to the SUbjects. Data collected shOUld 
not be of a nature that would be embarrassing to the SUbjec ts if it 
were to be associated with them. However, any information collected 
that could be associated with the subject will be kept strictly confi-
dential and will not be released without written permission from the 
subject and/or legal guardian.Subjects will not be identified by name, 
Social Security number, or medical record number in any part of the 
research paper which will result from this stUdy. 
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5. IDISOT Ra: "cqIy of dI. CXIIIEIIT Ra to be.lgned by die aDlect eff ~1c:8Dl.) ..uor MY n.t_t to be NtId 
the a&bject sIIould be UUc:h. to dli. f.... If no c:m.u .,... I. to be UNd, ~t til. prGCeclJres 
to be used to ___ diU Infrlne-tt ~ dI. aDlect" rlgllu witt not occur. 
D .. c:rtbe where .lgMd _ent forw witt be kept and for tlllat period of tl_. 
Signed consent forms viII be kept on file in the office of the 
physical therapy department at Trinity Nursing Home and viII 
be kept for a period of 3 years. 
6. For AU. la R£VIBI forwrd _ .IQI'IId original and twllve e12) ccpl .. of dli. COIIIPI.ted fol'll, and where appllcabl., 
twelve e12) capi .. of dI. propoMd _ fOl'll, ~tt_lres, .tc. and MY ~M:tng ~atlon to: 
Offlc. of R .... rcII ,PI'Oll .... D_l~t 
Unlveralty of North Duota 
lox .usa, University Station 
Grand Forb, IIorth Datota 5I2Q2 
On ~, _it to: OffIce of .... erdl' P~ D_l~, lox 134, or drop It off at R_ 101 Twadey Hatt. 
For EXEJFT or EIIPBIITm R£YJEII forwrd a signed orlgl,.l end a cqIy of the conI."t fol'll, ~tl_ires, etc. end ."., 
s~rting ~tation to _ ot til. edcireaHs above. 
- - - - - ---------- ------------------- ---------- --------- ---. - - ----
The polici .. and ~ on US. of "'-" Slo-l: ;ectl of dI. tkliverslty of IIorth Datots apply to _tt activities il'Mliving use 
-of HLftan Slbjects pertol"lled by I»rsomel c:oncU:"jng such actlvltl .. &nier dI" l;UlPicn of dI. Univershy. 110 Ktlviti .. aM! 
to be initiated without prior review and approval .. Pl"ftCl'lbC by dI. University's pollel .. end proc:ecU'ft governing die use 
of hu.n s&bjectl. 
SIIiIIA T1.ItES: 
DAlE: __________ _ 
Project Director or StUdent Advi.er 
DAlE: __________ _ 
DAlE: __________ _ 
Training or Center Grant Director 
eReviled 7'/1990) 
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APPENDIX 4: DATA COLLECTION SHEET 
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NAME: 
SEX: M F 
DIAGNOSES: 
KNEE ROM 
Left 
Right 
DATA COLLECTION SHEET 
Alzheimer's 
dementia 
1990 1991 
AGE: 
YEAR OF ONSET: 
rheumatoid arthritis 
Parkinson's osteoarthritis 
1992 
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CHANGE 
YEAR 1 
CHANGE TOTAL 
YEAR 2 CHANGE 
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